← FDA Drug Approvals (Drugs@FDA)
KONVOMEP
NDA · New Drug Application · Sponsor: AZURITY · Approved 2022-08-30
Drug application
- FDA Application #
NDA213593- Application type
- New Drug Application
- Brand name
- KONVOMEP
- Generic name
- OMEPRAZOLE AND SODIUM BICARBONATE
- Active ingredients
- OMEPRAZOLE; SODIUM BICARBONATE
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AZURITY
- Manufacturer
- Azurity Pharmaceuticals, Inc.
- First approval
- 2022-08-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown